ArticleCPT: pharmacometrics & systems pharmacology2022

Predicting disease activity in patients with multiple sclerosis: An explainable machine-learning approach in the Mavenclad trials.

Sreetama Basu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.